Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome

Atsuyuki Watanabe, Kengo Fukushima Kusano, Hiroshi Morita, Daiji Miura, Wakako Sumida, Shigeki Hiramatsu, Kimikazu Banba, Nobuhiro Nishii, Satoshi Nagase, Kazufumi Nakamura, Satoru Sakuragi, Tohru Ohe

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Aims: Arrhythmic storm or repetitive ventricular arrhythmia (VA) has been occasionally observed in Brugada syndrome (BS). A beta-adrenergic stimulator [isoproterenol (ISP)] has been reported to suppress this arrhythmic storm in sporadic cases. Accordingly, we investigated the antiarrhythmic effects of ISP infusion in consecutive BS patients with arrhythmic storm or repetitive VA. Methods and results: Seven BS patients with arrhythmic storm were studied. Intravenous ISP was administered as a bolus injection (1-2 μg), followed by continuous infusion (0.15 μg/min). Arrhythmic storm or repetitive VA was suppressed immediately after the bolus administration of ISP, which was followed by continuous infusion of low-dose ISP for 1-3 days. In all patients, ST-elevation decreased in right precordial leads. In six of the seven patients, VA subsided after the discontinuance of ISP. RR interval was shortened and ST-elevation in right precordial leads was decreased after ISP bolus injection. ST-elevation in right precordial leads remained decreased during continuous ISP infusion, whereas the RR interval returned to the control level. Conclusion: Continuous administration of low-dose ISP may be effective for the suppression of repetitive VA occurrence in patients with BS.

Original languageEnglish
Pages (from-to)1579-1583
Number of pages5
JournalEuropean Heart Journal
Volume27
Issue number13
DOIs
Publication statusPublished - Jul 2006

Fingerprint

Brugada Syndrome
Isoproterenol
Cardiac Arrhythmias
Injections
Adrenergic Agents

Keywords

  • Brugada syndrome
  • Isoproterenol
  • Ventricular arrhythmia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome. / Watanabe, Atsuyuki; Fukushima Kusano, Kengo; Morita, Hiroshi; Miura, Daiji; Sumida, Wakako; Hiramatsu, Shigeki; Banba, Kimikazu; Nishii, Nobuhiro; Nagase, Satoshi; Nakamura, Kazufumi; Sakuragi, Satoru; Ohe, Tohru.

In: European Heart Journal, Vol. 27, No. 13, 07.2006, p. 1579-1583.

Research output: Contribution to journalArticle

Watanabe, A, Fukushima Kusano, K, Morita, H, Miura, D, Sumida, W, Hiramatsu, S, Banba, K, Nishii, N, Nagase, S, Nakamura, K, Sakuragi, S & Ohe, T 2006, 'Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome', European Heart Journal, vol. 27, no. 13, pp. 1579-1583. https://doi.org/10.1093/eurheartj/ehl060
Watanabe, Atsuyuki ; Fukushima Kusano, Kengo ; Morita, Hiroshi ; Miura, Daiji ; Sumida, Wakako ; Hiramatsu, Shigeki ; Banba, Kimikazu ; Nishii, Nobuhiro ; Nagase, Satoshi ; Nakamura, Kazufumi ; Sakuragi, Satoru ; Ohe, Tohru. / Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome. In: European Heart Journal. 2006 ; Vol. 27, No. 13. pp. 1579-1583.
@article{2789bc0685e94405a044adee4a57e13a,
title = "Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome",
abstract = "Aims: Arrhythmic storm or repetitive ventricular arrhythmia (VA) has been occasionally observed in Brugada syndrome (BS). A beta-adrenergic stimulator [isoproterenol (ISP)] has been reported to suppress this arrhythmic storm in sporadic cases. Accordingly, we investigated the antiarrhythmic effects of ISP infusion in consecutive BS patients with arrhythmic storm or repetitive VA. Methods and results: Seven BS patients with arrhythmic storm were studied. Intravenous ISP was administered as a bolus injection (1-2 μg), followed by continuous infusion (0.15 μg/min). Arrhythmic storm or repetitive VA was suppressed immediately after the bolus administration of ISP, which was followed by continuous infusion of low-dose ISP for 1-3 days. In all patients, ST-elevation decreased in right precordial leads. In six of the seven patients, VA subsided after the discontinuance of ISP. RR interval was shortened and ST-elevation in right precordial leads was decreased after ISP bolus injection. ST-elevation in right precordial leads remained decreased during continuous ISP infusion, whereas the RR interval returned to the control level. Conclusion: Continuous administration of low-dose ISP may be effective for the suppression of repetitive VA occurrence in patients with BS.",
keywords = "Brugada syndrome, Isoproterenol, Ventricular arrhythmia",
author = "Atsuyuki Watanabe and {Fukushima Kusano}, Kengo and Hiroshi Morita and Daiji Miura and Wakako Sumida and Shigeki Hiramatsu and Kimikazu Banba and Nobuhiro Nishii and Satoshi Nagase and Kazufumi Nakamura and Satoru Sakuragi and Tohru Ohe",
year = "2006",
month = "7",
doi = "10.1093/eurheartj/ehl060",
language = "English",
volume = "27",
pages = "1579--1583",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "13",

}

TY - JOUR

T1 - Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome

AU - Watanabe, Atsuyuki

AU - Fukushima Kusano, Kengo

AU - Morita, Hiroshi

AU - Miura, Daiji

AU - Sumida, Wakako

AU - Hiramatsu, Shigeki

AU - Banba, Kimikazu

AU - Nishii, Nobuhiro

AU - Nagase, Satoshi

AU - Nakamura, Kazufumi

AU - Sakuragi, Satoru

AU - Ohe, Tohru

PY - 2006/7

Y1 - 2006/7

N2 - Aims: Arrhythmic storm or repetitive ventricular arrhythmia (VA) has been occasionally observed in Brugada syndrome (BS). A beta-adrenergic stimulator [isoproterenol (ISP)] has been reported to suppress this arrhythmic storm in sporadic cases. Accordingly, we investigated the antiarrhythmic effects of ISP infusion in consecutive BS patients with arrhythmic storm or repetitive VA. Methods and results: Seven BS patients with arrhythmic storm were studied. Intravenous ISP was administered as a bolus injection (1-2 μg), followed by continuous infusion (0.15 μg/min). Arrhythmic storm or repetitive VA was suppressed immediately after the bolus administration of ISP, which was followed by continuous infusion of low-dose ISP for 1-3 days. In all patients, ST-elevation decreased in right precordial leads. In six of the seven patients, VA subsided after the discontinuance of ISP. RR interval was shortened and ST-elevation in right precordial leads was decreased after ISP bolus injection. ST-elevation in right precordial leads remained decreased during continuous ISP infusion, whereas the RR interval returned to the control level. Conclusion: Continuous administration of low-dose ISP may be effective for the suppression of repetitive VA occurrence in patients with BS.

AB - Aims: Arrhythmic storm or repetitive ventricular arrhythmia (VA) has been occasionally observed in Brugada syndrome (BS). A beta-adrenergic stimulator [isoproterenol (ISP)] has been reported to suppress this arrhythmic storm in sporadic cases. Accordingly, we investigated the antiarrhythmic effects of ISP infusion in consecutive BS patients with arrhythmic storm or repetitive VA. Methods and results: Seven BS patients with arrhythmic storm were studied. Intravenous ISP was administered as a bolus injection (1-2 μg), followed by continuous infusion (0.15 μg/min). Arrhythmic storm or repetitive VA was suppressed immediately after the bolus administration of ISP, which was followed by continuous infusion of low-dose ISP for 1-3 days. In all patients, ST-elevation decreased in right precordial leads. In six of the seven patients, VA subsided after the discontinuance of ISP. RR interval was shortened and ST-elevation in right precordial leads was decreased after ISP bolus injection. ST-elevation in right precordial leads remained decreased during continuous ISP infusion, whereas the RR interval returned to the control level. Conclusion: Continuous administration of low-dose ISP may be effective for the suppression of repetitive VA occurrence in patients with BS.

KW - Brugada syndrome

KW - Isoproterenol

KW - Ventricular arrhythmia

UR - http://www.scopus.com/inward/record.url?scp=33745445929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745445929&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehl060

DO - 10.1093/eurheartj/ehl060

M3 - Article

C2 - 16760208

AN - SCOPUS:33745445929

VL - 27

SP - 1579

EP - 1583

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 13

ER -